Syazwani Itri Amran
TitleCited byYear
Isoform-selective inhibition of phosphoinositide 3-kinase: identification of a new region of nonconserved amino acids critical for p110α inhibition
Z Zheng, SI Amran, PE Thompson, IG Jennings
Molecular pharmacology 80 (4), 657-664, 2011
322011
Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis
Z Zheng, SI Amran, J Zhu, O Schmidt-Kittler, KW Kinzler, B Vogelstein, ...
Biochemical Journal 444 (3), 529-535, 2012
182012
Potent Inhibitors of Phosphatidylinositol 3 (PI3) Kinase that have Antiproliferative Activity Only When Delivered as Prodrug Forms
NJ O'Brien, S Amran, J Medan, B Cleary, LW Deady, IG Jennings, ...
ChemMedChem 8 (6), 914-918, 2013
52013
Biochemical and cellular studies of PI3 kinase inhibition
SI Amran
Monash University. Faculty of Pharmacy and Pharmaceutical Sciences …, 2015
2015
Mutagenesis of Specific Non-conserved Residues on PI3K for the Discovery of Isoform-selective PI3K Inhibitors
SI Amran
Monash University, 2008
2008
The system can't perform the operation now. Try again later.
Articles 1–5